Journal article
Prevalence and associations of general practitioners’ ordering of “non-symptomatic” prostate-specific antigen tests: A cross-sectional analysis
P Magin, A Tapley, A Davey, S Morgan, K Henderson, E Holliday, J Ball, N Catzikiris, K Mulquiney, N Spike, R Kerr, M van Driel
International Journal of Clinical Practice | WILEY | Published : 2017
DOI: 10.1111/ijcp.12998
Abstract
Aims: Testing for asymptomatic prostate cancer with prostate specific antigen (PSA) is of uncertain benefit. Most relevant authorities recommend against screening, and for informed patient choice. We aimed to establish the prevalence and associations of “non-symptomatic” PSA-testing of men aged 40 or older by early-career general practitioners (GP registrars). Methods: A cross-sectional analysis from the ReCEnT cohort study of registrars’ consultations, 2010-2014 (analysed in 2016). Registrars record 60 consecutive consultations each 6-month training term. The outcome factor was ordering an “asymptomatic” PSA test (a PSA ordered for an indication that was not prostate-related symptoms or pro..
View full abstractGrants
Funding Acknowledgements
The ReCEnT study is funded by the Australian Commonwealth Department of Health and, during the data collection period included in this study, by the participating educational organisations: General Practice Training Valley to Coast, the Victorian Metropolitan Alliance, General Practice Training Tasmania, Tropical Medicine Training, and Adelaide to Outback GP Training Program. The ReCEnT study is also supported by GP Synergy, the general practice Regional Training Organization for New South Wales and the Australian Capital Territory. These organisations are funded by the Australian Commonwealth Department of Health. The funders had no role in the conduct of the analysis or the interpretation or reporting of the results